Ionis 12-Month FCS Data Position Olezarsen For Near-Term Filing

 
• By Joseph Haas
  
Ionis's 12-month data strengthen rationale for olezarsen in FCS
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D